Select for export Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2022.2096 PubMed 36001306 Copy citation Copy BibTeX Unknown journal 2022-09-30 Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E Europe PMC Published psilocybin AddictionClinical TrialAdverse Events Clinical Trial More
Select for export Microdosing psilocybin for chronic pain: a case series. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/j.pain.0000000000002778 PubMed 36066961 Copy citation Copy BibTeX Pain 2022-09-04 Lyes M, Yang KH, Castellanos J, Furnish T. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221116926 PubMed 36017784 Copy citation Copy BibTeX Unknown journal 2022-08-25 Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. Europe PMC Published psilocybin AnxietyHeadache / MigraineClinical Trial Systematic Review More
Select for export The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/07067437221111371 PubMed 35975555 Copy citation Copy BibTeX Unknown journal 2022-08-16 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-07-24 University of California, San Diego ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.07.10.22277414 Copy citation Copy BibTeX medRxiv 2022-07-09 Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T medRxiv PREPRINT (not peer reviewed) psilocybin Headache / MigraineBrain ImagingMechanism of Action Clinical Trial More
Select for export Psychedelic use in India, its pattern and personal significance - findings from an online survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4103/indianjpsychiatry.indianjpsychiatry_447_21 PubMed 36060724 Copy citation Copy BibTeX Indian Journal of Psychiatry 2022-06-30 Gokul Raj OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-06-29 Wake Network, Inc. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1200/jco.2022.40.16_suppl.12097 Copy citation Copy BibTeX Journal of Clinical Oncology 2022-05-31 Manish Agrawal, Paul Thambi, Sarah Shnayder OpenAlex Published psilocybin DepressionAnxietyClinical Trial Clinical Trial More
Select for export Serotonin toxicity of serotonergic psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-05876-x PubMed 34251464 Copy citation Copy BibTeX Psychopharmacology 2022-05-31 Malcolm B, Thomas K PubMed Published psilocybin NeuroplasticityMechanism of ActionReceptor Pharmacology Review Article More
Select for export Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.06.6.30 Copy citation Copy BibTeX Psychiatric News 2022-05-22 Richard Karel OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2066650 PubMed 35426754 Copy citation Copy BibTeX Expert Opinion on Drug Safety 2022-04-26 Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Randomized Controlled Trial More
Select for export Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/molecules27082520 PubMed 35458717 Copy citation Copy BibTeX Unknown journal 2022-04-13 Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221084063 PubMed 35388724 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-04-06 Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. Europe PMC Published psilocybin AnxietySpiritualityObservational Study Observational Study More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0264927 PubMed 35294453 Copy citation Copy BibTeX PLoS ONE 2022-03-15 Dworatzyk K, Jansen T, Schmidt TT. Europe PMC Published psilocybin AnxietyConsciousnessMystical Experience Observational Study More
Select for export The therapeutic potential of psilocybin: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2047929 PubMed 35225143 Copy citation Copy BibTeX Unknown journal 2022-03-01 van Amsterdam J, van den Brink W. Europe PMC Published psilocybin Clinical TrialRandomized Controlled TrialSystematic Review Randomized Controlled Trial More
Select for export Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211069100 PubMed 35107059 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2022-02-28 Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ PubMed Published psilocybin Review ArticleHealthcare WorkersSafety Review Article More
Select for export The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2044096 PubMed 35225726 Copy citation Copy BibTeX Unknown journal 2022-02-27 Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
